Annovis Bio Analyst Price Targets - Benzinga

Annovis Bio Inc

ANVSNYSE

Trade with Public

Trade with Public

$1.08

N/A

Ult. Agg.: Nov 2, 6:16 PM

Panoramica Notizie Previsioni utili EventiObiettivi di prezzoDati finanziari Sentiment Azionariato Confronta Opzioni Rapporto azionario

Annovis Bio Analyst Price Targets - Benzinga

Annovis Bio Analyst Price Targets

Wall Street analyst price targets and consensus rating for Annovis Bio (ANVS).

Price Target Range — 9 Quarters

Analyst Consensus — 8 Analysts

6Buy

2Hold

Consensus RatingBuy# Analysts8Avg. Consensus PT$28Upside to Avg. PT+2481.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 28, 2026	Roth Capital	Boobalan Pachaiyappan	PT Cut	Buy	$8→$7
Aug 18, 2026	Canaccord Genuity	Sumant Kulkarni	Maintained	Buy	$17
Jul 8, 2026	Roth Capital	Boobalan Pachaiyappan	Initiate	Buy	$8
Apr 14, 2026	Canaccord Genuity	Sumant Kulkarni	Maintained	Buy	$17
Sep 30, 2025	Canaccord Genuity	Sumant Kulkarni	Maintained	Buy	$17
Sep 3, 2025	HC Wainwright & Co.	Raghuram Selvaraju	PT Cut	Buy	$12→$10
Jun 9, 2025	HC Wainwright & Co.	Raghuram Selvaraju	PT Cut	Buy	$30→$12
May 15, 2025	Canaccord Genuity	Sumant Kulkarni	PT Cut	Buy	$26→$17
Feb 10, 2025	D. Boral Capital	Jason Kolbert	Downgrade	Buy→Hold	—
Nov 11, 2024	D. Boral Capital	Jason Kolbert	Maintained	Buy	$21
Nov 11, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$30
Oct 25, 2024	Maxim Group	Jason McCarthy	Upgrade	Hold→Buy	$25
Oct 16, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$30
Oct 15, 2024	EF Hutton	Jason Kolbert	Maintained	Buy	$21
Oct 1, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$30
Aug 15, 2024	EF Hutton	Jason Kolbert	Maintained	Buy	$21
Aug 15, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$30
Aug 13, 2024	EF Hutton	Jason Kolbert	Initiate	Buy	$21
Jul 17, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$30
Jul 11, 2024	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$23→$30

Analyst Ratings News

PRO
Roth Capital Maintains Buy on Annovis Bio, Lowers Price Target to $7

Roth Capital analyst Boobalan Pachaiyappan maintains Annovis Bio (NYSE:ANVS) with a Buy and lowers the price target from $8 to $7.

Benzinga Newsdesk

PRO
Roth Capital Initiates Coverage On Annovis Bio with Buy Rating, Announces Price Target of $8

Roth Capital analyst Boobalan Pachaiyappan initiates coverage on Annovis Bio (NYSE:ANVS) with a Buy rating and announces Price Target of $8.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Buy on Annovis Bio, Maintains $17 Price Target

Canaccord Genuity analyst Sumant Kulkarni maintains Annovis Bio (NYSE:ANVS) with a Buy and maintains $17 price target.

Benzinga Newsdesk

Alphabet To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Wednesday

Avi Kapoor

PRO
HC Wainwright & Co. Maintains Buy on Annovis Bio, Lowers Price Target to $10

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Annovis Bio (NYSE:ANVS) with a Buy and lowers the price target from $12 to $10.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Annovis Bio, Lowers Price Target to $12

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Annovis Bio (NYSE:ANVS) with a Buy and lowers the price target from $30 to $12.

Benzinga Newsdesk